Floris A. van de Laar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Floris A. van de Laar has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Annemarie A. Uijen
Department of Primary and Community Care, Radboud University Medical Center, Radboud Institute of Medical Innovation, Nijmegen, the Netherlands
1 shared publication - Dries van Sleeuwen
Department of Primary and Community Care, Radboud University medical center, Nijmegen, the Netherlands
1 shared publication - Jan P. Vandenbroucke
London School of Hygiene and Tropical Medicine
1 shared publication - Marcel M. C. Hovens
Department of Internal Medicine, Rijnstate Hospital, Arnhem, The Netherlands
1 shared publication Marco Peters
Department of Intensive Care, Canisius Wilhelmina Ziekenhuis, Nijmegen, The Netherlands
1 shared publication- Marieke Zegers
Radboud University Medical Center, Department of Intensive Care Medicine, Nijmegen, The Netherlands
1 shared publication
Latest Publications
- Open Access
- 8 May 2026
- Published by Springer Nature in BMC Primary Care
- Vol. 27
Likelihood of breast cancer among women presenting with breast-related symptoms in primary care, with a focus on isolated mastalgia: a retrospective cohort study
Background: Breast-related symptoms are common in primary care and frequently prompt imaging or referral. While a palpable breast lump is strongly associated with breast cancer, isolated mastalgia is generally considered low risk. Most evidence comes from secondary care, limiting applicability to general practice. Aim: To estimate the likelihood of breast cancer associated with breast-related symptoms in primary care and to evaluate current GP management of women with isolated mastalgia. Design and setting: Retrospective cohort study using electronic health records from a Dutch primary care research network. Methods: We included women aged ≥ 30 years presenting with breast-related symptoms or diagnosed with breast cancer between 2014 and 2021. Multivariable logistic regression assessed associations between symptoms and breast cancer. Mastalgia was classified as either isolated (without any other breast-related symptoms) or in combination with other symptoms. In women with isolated mastalgia, GP-initiated imaging and referrals were recorded and evaluated. Results: We included 2073 episodes from 1752 women (median age: 45.0 years, range 30–100 years); 189 episodes (9.1%) resulted in breast cancer. Presentation with a breast lump (OR 10.57, 95%-CI 4.89–22.84), skin or nipple retraction (OR 5.54, 95%-CI 2.28–13.48), and increasing age (OR 1.07 per year, 95%-CI 1.05–1.08) were independently associated with breast cancer. Mastalgia was associated with lower odds (OR 0.56, 95%-CI 0.34–0.92). Mastalgia was reported in 26 episodes that ultimately resulted in a breast cancer episode, but no cases occurred among women with isolated mastalgia (0 of 588 episodes). Despite this, 39.6% of women with isolated mastalgia underwent breast imaging, nearly half within three months. Conclusion: In primary care, breast cancer is strongly associated with a palpable lump, skin or nipple retraction, and increasing age. Isolated mastalgia was not associated with breast cancer. However, mastalgia occurring in combination with other breast-related symptoms may indicate a higher risk. Imaging and referral may often be safely deferred in women presenting with short-duration isolated mastalgia.
- 8 May 2026
- Published by Springer Nature in BMC Primary Care
- Vol. 27
Open AccessLikelihood of breast cancer among women presenting with breast-related symptoms in primary care, with a focus on isolated mastalgia: a retrospective cohort study
Background: Breast-related symptoms are common in primary care and frequently prompt imaging or referral. While a palpable breast lump is strongly associated with breast cancer, isolated mastalgia is generally considered low risk. Most evidence comes from secondary care, limiting applicability to general practice. Aim: To estimate the likelihood of breast cancer associated with breast-related symptoms in primary care and to evaluate current GP management of women with isolated mastalgia. Design and setting: Retrospective cohort study using electronic health records from a Dutch primary care research network. Methods: We included women aged ≥ 30 years presenting with breast-related symptoms or diagnosed with breast cancer between 2014 and 2021. Multivariable logistic regression assessed associations between symptoms and breast cancer. Mastalgia was classified as either isolated (without any other breast-related symptoms) or in combination with other symptoms. In women with isolated mastalgia, GP-initiated imaging and referrals were recorded and evaluated. Results: We included 2073 episodes from 1752 women (median age: 45.0 years, range 30–100 years); 189 episodes (9.1%) resulted in breast cancer. Presentation with a breast lump (OR 10.57, 95%-CI 4.89–22.84), skin or nipple retraction (OR 5.54, 95%-CI 2.28–13.48), and increasing age (OR 1.07 per year, 95%-CI 1.05–1.08) were independently associated with breast cancer. Mastalgia was associated with lower odds (OR 0.56, 95%-CI 0.34–0.92). Mastalgia was reported in 26 episodes that ultimately resulted in a breast cancer episode, but no cases occurred among women with isolated mastalgia (0 of 588 episodes). Despite this, 39.6% of women with isolated mastalgia underwent breast imaging, nearly half within three months. Conclusion: In primary care, breast cancer is strongly associated with a palpable lump, skin or nipple retraction, and increasing age. Isolated mastalgia was not associated with breast cancer. However, mastalgia occurring in combination with other breast-related symptoms may indicate a higher risk. Imaging and referral may often be safely deferred in women presenting with short-duration isolated mastalgia.
- 14 November 2023
- Published by Springer Nature
- p. 1025-1028
Brandende voeten
- Open Access
- 30 May 2023
- Published by Taylor & Francis in European Journal of General Practice
- Vol. 29 (1) , 2213476
Post-intensive care syndrome in primary care: The development of new diseases and primary care services utilisation – a prospective cohort study
Patients experience long-lasting health problems defined as post-intensive care syndrome (PICS) after Intensive Care Unit (ICU) admission. Little is known about PICS in primary care. To investigate whether ICU survivors encounter more new International Classification of Primary Care-2 (ICPC-2) diagnoses and general practitioner (GP) contact compared to patients with similar comorbidity without ICU admission. Prospective multicentre cohort study in three Dutch general practices. Numbers of disease-episodes and GP contacts of ICU survivors ≥ 16 years admitted between 2008 and 2017 were extracted from GPs' information systems. A non-ICU reference cohort was matched 1:1 for age, sex, follow-up period and comorbidity groups from patients' medical history. Negative binominal regression analysis was used to compare both cohorts 0-3, 3-6, 6-12 months, 1-2 and 2-5 years after ICU admission and 1 year prior to admission. ICU survivors (n = 199) encountered more new disease-episodes 1 year before (mean 3.97 (95% confidence interval [CI] 3.50-4.52]]; reference 2.36 [1.28-3.17]) to 2-5 years after ICU admission (3.65 [3.15-4.26]; reference 2.86 [2.52-3.22]). ICU survivors also had more GP contacts 1 year before (mean 19.61 [17.31-22.17]; reference 10.02 [7.81-12.38]) to 2-5 years after ICU admission (18.53 [15.58-21.85]; reference 12.03 [10.33-13.91]). Patients with prior ICU admission did not encounter patterns in specific ICPC-2 chapters compared to non-ICU patients. Patients admitted to the ICU encounter more new primary care disease-episodes and GP contacts. As patients present their symptoms to their GP first, it is therefore up to the GP to recognise these critical illness-related symptoms.
- 30 May 2023
- Published by Taylor & Francis in European Journal of General Practice
- Vol. 29 (1) , 2213476
Open AccessPost-intensive care syndrome in primary care: The development of new diseases and primary care services utilisation – a prospective cohort study
Patients experience long-lasting health problems defined as post-intensive care syndrome (PICS) after Intensive Care Unit (ICU) admission. Little is known about PICS in primary care. To investigate whether ICU survivors encounter more new International Classification of Primary Care-2 (ICPC-2) diagnoses and general practitioner (GP) contact compared to patients with similar comorbidity without ICU admission. Prospective multicentre cohort study in three Dutch general practices. Numbers of disease-episodes and GP contacts of ICU survivors ≥ 16 years admitted between 2008 and 2017 were extracted from GPs' information systems. A non-ICU reference cohort was matched 1:1 for age, sex, follow-up period and comorbidity groups from patients' medical history. Negative binominal regression analysis was used to compare both cohorts 0-3, 3-6, 6-12 months, 1-2 and 2-5 years after ICU admission and 1 year prior to admission. ICU survivors (n = 199) encountered more new disease-episodes 1 year before (mean 3.97 (95% confidence interval [CI] 3.50-4.52]]; reference 2.36 [1.28-3.17]) to 2-5 years after ICU admission (3.65 [3.15-4.26]; reference 2.86 [2.52-3.22]). ICU survivors also had more GP contacts 1 year before (mean 19.61 [17.31-22.17]; reference 10.02 [7.81-12.38]) to 2-5 years after ICU admission (18.53 [15.58-21.85]; reference 12.03 [10.33-13.91]). Patients with prior ICU admission did not encounter patterns in specific ICPC-2 chapters compared to non-ICU patients. Patients admitted to the ICU encounter more new primary care disease-episodes and GP contacts. As patients present their symptoms to their GP first, it is therefore up to the GP to recognise these critical illness-related symptoms.
- Open Access
- 1 July 2005
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (7) , 1841
α-Glucosidase Inhibitors for Patients With Type 2 Diabetes
- 1 July 2005
- Published by American Diabetes Association in Diabetes Care
- Vol. 28 (7) , 1841
Open Accessα-Glucosidase Inhibitors for Patients With Type 2 Diabetes